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Abstract
 .  .The role of phospholipase A PLA and its metabolite arachidonic acid AA in the proliferation and differentiation of2 2
  . .  .HL-60 cells was investigated. Addition of either 1,25-dihydroxyvitamin D 1,25 OH D or retinoic acid RA to HL-603 2 3
w3 xcells for 2 h inhibited PMA-stimulated PLA activity measured by H AA release. The inhibitor of PLA activity,2 2
 .p-bromophenacyl bromide BPB , significantly inhibited the proliferation of HL-60 cells and of fibroblast L929 and Swiss
3T3 cells in a dose-dependent manner. The effect of BPB on proliferation is probably through its inhibitory effect on PLA 2
w3 xactivity, since the same doses of BPB which inhibited proliferation also inhibited PLA activity determined by H AA2
release. The importance of PLA activity for cell growth was further supported by the effect of two other PLA inhibitors,2 2
AACOCF and scalaradial, which inhibited HL-60 proliferation in a dose-dependent manner. BPB, AACOCF and3 3
scalaradial significantly increased the doubling time to 32.4 h, 34.0 h and 31.8 h, respectively, compared with 24.6 h in the
control. The inhibitory effect of BPB on HL-60 proliferation was reversed by addition of exogenous free AA to HL-60
cells, indicating the importance of this metabolite for the proliferation process. This reversible effect is specific for AA
 .  .since it was not achieved by other fatty acids like linolenic acid LA or oleic acid OA . Addition of free AA to HL-60
cells did not induce differentiation, as expected. Although BPB, AACOCF , or scalaradial inhibited proliferation, they did3
 .not induce differentiation nor affect the differentiation induced by 1,25 OH D or RA. These results implicate that PLA2 3 2
activity has no regulatory role in differentiation of HL-60 cells. The differential effect of PLA inhibitors on proliferation2
and differentiation of HL-60 cells suggests that these two processes function under different regulatory mechanisms.
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1. Introduction
Research into the biology of human leukemia has
not only led to important advances in the understand-
) Corresponding author at: Faculty of Health Sciences, Ben-
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q972 7 6467477.
ing of this disease, but has provided some useful
models for the study of cellular development.
Leukemia-derived human myeloid cell lines, such as
the promyelocytic HL-60 cell line, are often used as
models to study terminal differentiation of
 .myelomonocytic cells. Dimethylsulfoxide DMSO ,
 .retinoic acid RA and other substances induce HL-60
cells to differentiate along the myeloid lineage,
 .whereas 12-phorbol-13-acetate PMA , IFN-g , and
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 .1,25 OH D induce them to differentiate to cells2 3
w xwith characteristics of monocytermacrophages 1–5 .
However, the signaling pathways responsible for in-
duction of differentiation remain unclear.
Recent studies have suggested that calcium-depen-
 .dent phospholipase A PLA and its metabolites2 2
participate in the differentiation process. Some groups
w x6–9 have shown that the activity of PLA was2
elevated during HL-60 cell differentiation induced by
RA or DMSO to the granulocyte phenotype, or by
 .1,25 OH D , PMA, or IFN-g to the monocyte phe-2 3
 .notype. Arachidonic acid AA as well as some of the
AA metabolites can act as first and second messen-
w xgers 10 . It has been suggested that AA metabolites
are involved in the transcriptional and post-transcrip-
tional regulation of gene expression. For instance,
AA metabolites regulate c-fms gene expression dur-
ing monocytic differentiation induced by phorbol es-
w xter 11 , and gene expression of the macrophage-
specific colony stimulating factor in HL-60 cells
w xinduced by TNF 12 . In previous studies, we demon-
strated the requirement of calcium ions for the differ-
 .entiation of HL-60 cells induced by 1,25 OH D2 3
w x13 . This calcium requirement may be due to cal-
cium-dependent PLA activity required for the dif-2
ferentiation process.
In the present study, the role of PLA in inhibiting2
proliferation and inducing differentiation to either the
monocyte or granulocyte phenotype was studied. Our
results indicate that PLA activity is essential for the2
proliferation process of both HL-60 cells and fibrob-
last cell lines, however, has no effect on differentia-
tion of HL-60 cells.
2. Materials and methods
 .1,25 OH D was kindly provided by Dr. M.2 3
Uskokovich from Hoffmann La-Roche Inc., Nutley,
w . .NJ. 5a,12a,17ab -12-acetyl-oxy 4,48-trimethyl-D-
.xhomoandrost-16ene-17,17a-dicarboxaldehyde
 .scalaradial and arachidonyltrifluoromethyl ketone
 .AACOCF were purchased from Biomol Research3
Laboratories Inc. Plymouth Meeting, PA. These com-
pounds were reconstituted in ethanol, stored in con-
centrated solutions at y208C, and diluted in the
appropriate medium before each experiment. Retinoic
 .acid Sigma Chemical Co., St. Louis, MO was freshly
dissolved in ethanol before each experiment. The
concentration of ethanol added to the cells did not
w3 x  .exceed 0.1%. H arachidonic acid 100 Cirmmol
was purchased from New England Nuclear, Boston,
 . w MA. b-Bromophenacyl bromide BPB , 3- 4,5-di-
.methylthiazole-2-yl -2,5-diphenyl tetrazolium bro-
x  . w mide MTT , 2,3-bis 2-methoxy-4-nitro-5-
. w . xsulfophenyl -5- phenylamino carbonyl -2H- tetra-
x  .zolium hydroxide XTT , phenazine methosulfate
 .  .  .PMS , linolenic acid LA , oleic acid OA , RNase
and propidium iodide were from Sigma Chemical
3 Co., St. Louis, MO. Thymidine-methyl- H 51.6
.Cirmmol was purchased from Rotem Industries,
Nuclear Research Center-Negev, Beer Sheva, Israel.
2.1. Cell culture
HL-60 cells were grown in stationary suspension
culture in RPMI-1640 medium containing 10% fetal
calf serum, 2 mM L-glutamine, 100 Urml penicillin,
100 mgrml streptomycin and 12.5 Urml nystatin
 .Biological Industries, Beth Haemek, Israel at 378C
in a humidified atmosphere of 5% CO and 95% air.2
HL-60 cell concentration was 2=105 cellsrml at the
time that inducers of differentiation were added to the
culture.
Fibroblast L929 and Swiss 3T3 cells were main-
tained in Dulbecco’s modified minimal essential
 .medium DMEM containing 10% fetal calf serum, 2
mM L-glutamine, 100 Urml penicillin, 100 mgrml
streptomycin and 12.5 Urml nystatin in an atmo-
sphere of 5% CO at 378C.2
2.2. Cell number determination
Cell number was counted by coulter counter and
hemacytometer. Cell viability was determined by try-
w xpan blue exclusion 14 . In all experiments, the per-
centage of viable cells was )95%.
[ 3 ]2.3. H Thymidine incorporation
 .Equal volumes 100 ml of cell culture were placed
 .in triplicate into 96-well plates Nunc, Denmark
w x13 . Cells were pulsed with 1.25 mCirwell
w3 xH thymidine for 3 h at 378C and harvested onto
glass fiber filters with a Titertek Cell Harvester
 .Skatron Lierbyen, Norway . After incubation with
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w3 xH thymidine for 3 h at 378C, fibroblasts were re-
placed with 50 mlrwell tripsin-EDTA solution for 30
min. Typsinization was terminated by adding DMEM
medium. Radioactivity bound to dry filters was deter-
mined using a Bio-Imaging Analyzer Fuji Photo
.Film Co., Japan .
2.4. Estimation of the number of ˝iable cells
w This was carried out by the 3- 4,5-dimethylthia-
. x  .zole-2-yl -2,5-diphenyl tetrazolium bromide MTT
w x w reduction assay 15 or by 2,3-bis 2-methoxy-4-nitro-
. w . x5-sulfophenyl -5- phenylamino carbonyl -2H-tetra-
 . w xzolium hydroxide XTT reduction assay 16 . The
blue formazan produced in these assays by mitochon-
drial dehydrogenases is proportional to the number of
viable cells.
2.5. MTT assay
The culture medium from cells grown in 96-well
 .microplates was removed, 50 ml MTT 500 mgrml
was added to each well and incubation was carried
out for 1.5 h at 378C. Subsequently, the MTT solu-
tion was removed and replaced with 100 ml DMSO.
The plates were vigorously shaken for 20 min on a
shaking plate Pathodx rotator, Diagnostic Products
.Corp. at room temperature. The optical density of
each well was measured on a Thermomax Microplate
 .Reader Molecular Devices, Melno Park, CA using a
test wavelength of 550 nm and a reference wave-
length of 630 nm.
2.6. XTT assay
 .25 ml of XTT solution 1 mgrml and PMS at
final concentration of 125 mM were added to each
well which contained 100 ml HL-60 cell culture.
After incubation for 4 h at 378C the plates were
mixed on a shaker Pathodx rotator, Diagnostic Prod-
.ucts Corp. and the optical density of each well was
measured on a Thermomax Microplate Reader
 .Molecular Devices, Melno Park, CA using a test
wavelength of 450 nm and a reference wavelength of
650 nm.
The results of parallel estimations, under different
experimental conditions, by direct counting of trypan
blue excluded cells and MTT or XTT colorimetric
 .method strongly correlated with each other rs0.99 .
Since the O.D. values higher than 1.0 were not linear,
results were transferred to the cell numbers.
2.7. Flow cytometry
HL-60 cells were treated with or without
 .1,25 OH D , RA, BPB, AACOCF3 or scalaradial2 3
 6.for 2 days as described above. Cells 10 were
collected, washed with PBS and fixed in 70% ethanol
for one day at y208C. Cells were then washed with
PBS, treated for 40 min with 10 mgrml RNase at
room temperature and then stained with propidium
iodide at a final concentration of 150 mgrml. Result-
ing DNA distributions were then analyzed for propor-
tion of cells in G rG , S, and G rM of the cell0 1 2
cycle. Data were collected with a FACScan Flow
 .Cytometer Becton-Dickinson, San Jose, CA and
analyzed using the PC-Lysys program Becton-Dick-
.inson . All experiments were repeated at least three
times, each in duplicate.
2.8. Determination of differentiation
Differentiation was measured by superoxide gener-
w xation detected by cytochrome c reduction 17 . The
 y.production of superoxide anion O was measured2
as the superoxide dismutase inhibitable reduction of
ferricytochrome c by the microtiter plate technique.
 5 .Cells 2.5=10 cellsrwell were suspended in 100
 .ml Hanks’ Balanced Salts Solution HBSS contain-
 .ing ferricytochrome c 150 mM . Superoxide produc-
tion by the cells was stimulated with the addition of
 .PMA 50 ngrml . The reduction of ferricytochrome
c was followed by the change of absorbance at 550
nm every 2 min on a Thermomax Microplate Reader
 .Molecular Devices, Melno Park, CA . The maximal
rates of superoxide generation were determined and
expressed as nmoles Oyr106 cellsrmin using the2
extinction coefficient E s21 mMy1 cmy1.550
2.9. PLA acti˝ity2
PLA activity was assayed by measuring the re-2
lease of radiolabeled arachidonic acid in the presence
w x 8and absence of inhibitors 18 . 10 cellsrml were
incubated for 1 h at 378C in Ca2qrMg2q-free PBS
w3 x  .containing 1.5 mCi H AA 100.00 Cirmmol . Cells
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were washed once with PBS containing 0.1% fatty
acids free human serum albumin and twice with PBS.
The pellet was resuspended to 107 cellsrml in PBS
with 0.9 mM CaCl and 0.5 mM MgCl containing2 2
0.1% human serum albumin. The incorporation of
w3 x w3 xH AA was measured. The release of H AA was
measured after incubation with the appropriate stimu-
lus at 378C. The reactions were terminated by cen-
trifugation at 48C and samples of the supernatants
were counted using a liquid scintillation spectrometer
 .Packard 1900CA spectrometry .
2.10. Isolation of total RNA, amplification and detec-
tion
107 Cultured cells were washed twice with phos-
phate buffered saline, placed directly into 1 ml RNA-
 .zol B Biotecx Laboratories, Houston, TX and stored
at y708C until further processing to isolate RNA.
RNA isolation was performed in a single step method
w xas described by Chomezynski and Sacchi 19 . Total
cellular RNA was reverse transcribed in a 20-ml
reaction volume with 1=RT buffer Gibco BRL Life
.  .Technologies , dithiothreitol 1.25 mM Gibco BRL ,
0.5 mM dNTPs Boehringer Mannheim GmbH, Ger-
. many , 65 U ribonuclease inhibitor Amersham Life
.  .  .Science, UK , 200 ng primer p dT Boehringer15
and 200 U M-MLV reverse transcriptase Gibco
.BRL . The reverse transcriptase enzyme was inacti-
vated by heating the mixture to 658C for 10 min. The
 .cytosolic PLA cPLA primer pair was constructed2 2
w xaccording to the cDNA sequence of cPLA 20 . It2
amplified a 628-bp using upstream primer: 5X-CTCT-
TGAAGTTTGCTCATGCCCAGAC-3X; and down
stream primer: 5X-GCAAACATCAGCTCTGAA-
X  .ACGTCAGG-3 . The secreted PLA sPLA primer2 2
pair was constructed according to the cDNA se-
w xquence of sPLA 21 . It amplified a 278 bp PCR2
product and was composed of the following se-
quences, upstream primer: 5X-CACAGAAT-
GATCAAGTTGACGGGA-3X; and down stream
prim er: 5X-A A A CA G G TG G CA G CA G CCT -
TATCACA-3X. The PCR conditions were found to
amplify cDNA molecules in a linear fashion. The
PCR amplification reaction mixture contained: 5 ml
cDNA, 1.25 U Taq DNA polymerase USA Appli-
.gene, Pleasanton, CA , 1=Taq polymerase buffer,
 .0.5 mM dNTPs Boehringer and 1.5 mM of each
primer. The PCR amplification was carried out in a
microprocessor controlled incubation system,
 .Crocodile II Apligene . After the mixture was pre-
heated at 958C for 3 min, amplification was per-
formed using a step program 948C, 1 min; 608C, 2
.min; 728C, 3 min followed by a 5 min final exten-
sion at 728C. The product were electrophoresed on a
2% agarose International Biotechnologies, New
.Haven, CT and stained with ethidium bromide.
2.11. Statistical analysis
The differences in means were analyzed by Stu-
dent’s t test. The plots were drawn as least-square
regression lines and tested by analysis of variance.
3. Results
 .The effect of 1,25 OH D or RA on PLA activ-2 3 2
w3 xity measured by H AA release in HL-60 cells was
determined in order to study the involvement of
PLA activity in the proliferation and differentiation2
processes. As shown in Fig. 1, incubation of HL-60
w xcells with optimal concentrations 17 of either
 .  .  .1,25 OH D 50 nM or RA 1 mM for 2 h signifi-2 3
 . w3 xcantly P-0.001 inhibited the release of H AA
stimulated by 100 ngrml PMA. Shorter incubation of
 .HL-60 cells with either 1,25 OH D or RA did not2 3
 .Fig. 1. The effect of 1,25 OH D or RA on the release of2 3
w3 xH AA stimulated by PMA in undifferentiated HL-60 cells.
w3 xPrelabeled HL-60 cells with H AA were incubated with either
 .50 nM 1,25 OH D or 1 mM RA for 2 h before stimulation by2 3
w3 x100 ngrml PMA. The results show the release of H AA during
2 h of stimulation. There were significant differences in the
w3 x  .release of H AA in the presence of 1,25 OH D or RA2 3
) .compared with the control P -0.001 . The data are the
mean"S.E.M. from 4 experiments, each in duplicate.
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Fig. 2. The effect of BPB on HL-60 cell proliferation. Cell
 . w3 xnumber was determined by XTT a or H thymidine incorpora-
 .tion b . There was a significant inhibitory effect of BPB on
) )) .HL-60 cell proliferation P -0.05, P -0.005 . The results
are the mean"S.E.M. 3 days after addition of BPB in culture
from 3 experiments, each in triplicate.
w3 xcause significant inhibition of H AA release. Either
 .1,25 OH D or RA alone did not affect the release2 3
w3 xof H AA.
The effect of the PLA inhibitor, b-bromophena-2
 .cyl bromide BPB , on the proliferation of HL-60
cells was studied. Fig. 2 shows that BPB significantly
inhibited the proliferation of HL-60 cells in a dose-
dependent manner in a range of 0.1–0.75 mM. BPB
 .0.75 mM caused maximum inhibition of 43.2"
1.7% or 46.3"3.5%, measured by XTT or by thymi-
dine incorporation, respectively. The concentration of
BPB up to 0.75 mM did not affect cell viability as
determined by trypan blue exclusion; higher concen-
 .trations of BPB from 1 mM were toxic. The in-
hibitory effect of BPB is time-dependent and maxi-
mum inhibition was obtained at day 3, as shown in
Fig. 3.
w3 xPLA activity measured by H AA release from2
prelabeled cells was examined in HL-60 cells incu-
bated with 0.75 mM BPB. As shown in Fig. 4,
w3 xH AA release stimulated by 100 ngrml PMA was
significantly inhibited in HL-60 cells during two days
of culture with 0.75 mM BPB. Higher doses of BPB
 .5 mM or 10 mM caused an immediate inhibition of
w3 xthe release of H AA stimulated by 100 ngrml
PMA in uninduced HL-60 cells 40% and 72% inhi-
.bition, respectively .
The inhibition of HL-60 cell proliferation caused
by BPB could be reversed by the addition of exoge-
nous free AA to the culture. As shown in Fig. 5, in
the presence of 0.75 mM BPB HL-60 proliferation
reached 74.0"4.8% of the control at day 2. 24 h
after addition of free AA in a range of 40 mM to 80
mM, the cell number significantly increased in a dose
dependent manner. 80 mM AA caused a maximum
reversible effect reaching 101.4"5.1% of control
compared with 56.8"1.7% of control on day 3
without addition of AA. To study whether this re-
versible effect is specific for AA, the effect of the
other fatty acids, LA or OA, was analyzed. LA or
OA in a range of 40 mM to 100 mM did not reverse
 .the inhibition induced by BPB data not shown .
As shown in Fig. 6, the presence of two types of
PLA ; cPLA and sPLA could be demonstrated in2 2 2
Fig. 3. The effect of BPB on HL-60 cell proliferation during 4
days. BPB at final concentration of 0.75 mM was added at day 0.
Cell number was determined by XTT. The results, expressed as
percentages of control, are the mean"S.E.M. from 3 experi-
ments, each in triplicate.
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w3 xFig. 4. The effect of BPB on H AA release from undifferenti-
ated HL-60 cells stimulated by PMA. BPB at a low concentration
w3 xof 0.75 mM for one or two days inhibited H AA release from
 . undifferentiated HL-60 cells a . BPB at high concentrations 5
.  . w3 xmM, 10 mM b rapidly inhibited H AA release from undiffer-
w3 xentiated HL-60 cells. The results represent the release of H AA
for 10 min and are expressed as percentage of control shown
from a representative experiment of 3 independent experiments,
each in duplicate.
HL-60 cells. The detection of cPLA - and sPLA -2 2
mRNA was performed by RT-PCR amplification of
specific fractions of 628 bp and of 278 bp, respec-
tively. The primers used in these reactions were
constructed according to the published cDNA se-
quences as described in the Materials and Methods
section.
The effect of two other inhibitors of PLA activ-2
ity, AACOCF and scalaradial, on HL-60 cell prolif-3
eration was studied as well. As shown in Fig. 7, these
two inhibitors significantly inhibited HL-60 cell pro-
liferation in a dose dependent manner. The maximal
inhibition was reached at day three: 41.8"1.9% and
43.8"2.0% by 30 mM AACOCF and 7.5 mM3
scalaradial, respectively. Similar to the effect of BPB,
AACOCF and scalaradial suppressed HL-60 prolif-3
Fig. 5. The reversible effect of AA on the inhibition of HL-60
proliferation caused by BPB. HL-60 cells were cultured in the
presence or absence of 0.75 mM BPB for 2 days. Then exoge-
 .nous free AA 40–80 mM was added to cell culture. The
proliferation was determined by XTT during 3 days. The re-
versible effect of AA on HL-60 cell proliferation is significant
 .P -0.001 . The results are the mean"S.E.M. from 3 experi-
ments, each in triplicate.
eration as a function of time reaching the maximum
 .effect at day three Fig. 8 .
In order to determine whether PLA inhibitors2
cause arrest at a specific phase of the cell cycle, we
studied their effect on the cell cycle by flow cytome-
try. Our results showed that there is no specific arrest
at any phase of the cell cycle in contrast to
 .  .  .1,25 OH D 50 nM and RA 1 mM which ar-2 3
Fig. 6. RT-PCR analysis of cPLA and sPLA in undifferenti-2 2
ated HL-60 cells. The amplification of 628 bp of cPLA and 2782
bp of sPLA are shown by arrows. The first lane shows the 1232
bp size marker.
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 .Fig. 7. The effect of PLA inhibitors, AACOCF a and scalara-2 3
 .dial b , on HL-60 cell proliferation. Cell number was counted by
Coulter Counter. There was a significant inhibitory effect on
) )) .HL-60 cell proliferation P -0.03, P -0.005 . The results
are the mean"S.E.M. 3 days after addition of inhibitor in culture
from 3 experiments, each in duplicate.
 .rested the HL-60 cell cycle at G Table 1 . However,1
the three PLA inhibitors decreased the proliferation2
rate of HL-60 cells. As shown in Fig. 9, BPB at 0.75
mM, AACOCF at 30 mM, and scalaradial at 7.53
mM significantly increased the doubling time of HL-
60 cells from 24.6 h in the control to 32.4 h, 34.0 h
and 31.8 h, respectively.
In order to confirm the necessity of PLA activity2
for the proliferation process, the role of PLA on2
proliferation in other cell lines, fibroblast L929 and
S3T3 cells, was studied. 5=104rml L929 or 2=
104rml S3T3 were cultured in the absence or in the
Fig. 8. The effect of AACOCF and scalaradial on HL-60 cell3
proliferation during 3 days. Cell number was counted by Coulter
 .  .Counter. AACOCF v or scalaradial ‘ was added to cell3
culture at a final concentration of 30 mM and 7.5 mM, respec-
tively at day 0. The results are the mean"S.E.M. 3 days after
addition of inhibitor in culture from 3 experiments, each in
duplicate.
presence of three different concentrations of BPB.
BPB significantly inhibited fibroblast proliferation in
a dose-dependent manner, achieving maximum effect
Fig. 9. Growth curves for HL-60 cells treated with or without
PLA inhibitors were generated from cell counts performed at2
approximately 24-h intervals. The doubling time was calculated
from the slope of the logarithmic growth phase of the growth
curve. The data are derived from three independent experiments
 . in duplicate. Symbols: BPB 0.75 mM, B ; AACOCF 30 mM,3
.  .  .‘ ; scalaradial 7.5 mM ’ ; and control v .
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Table 1
 .The effects of 1,25 OH D , RA, BPB, AACOCF , and scalara-2 3 3
dial on cell cycle in HL-60 cells
 .  .  .G rG % S % G qM %0 1 2
Control 42.1"2.3 46.2"2.2 11.7"0.1
 .1,25 OH D 68.4"1.2 21.9"0.8 9.7"0.92 3
RA 59.1"1.5 30.4"1.0 10.5"0.7
BPB 42.0"0.2 44.2"1.0 13.8"1.1
AACOCF 44.9"2.9 45.0"3.6 11.1"0.73
scalaradial 46.5"2.2 41.6"0.7 11.9"1.5
 .Cells were exposed to 50 nM 1,25 OH D , 1 mM RA, 0.75 mM2 3
BPB, 30 mM AACOCF , or 7.5 mM scalaradial for 2 days before3
processing as described in Section 2. The results are mean"S.D.
of 3 independent experiments.
on day three. As shown in Fig. 10a, in the presence
of 1 mM BPB, the growth of fibroblast L929 mea-
sured by MTT was 54.6"7.4% of the control and
growth of fibroblast Swiss 3T3 cell line was 37.2"
Fig. 10. The effect of BPB on fibroblast L929 and Swiss 3T3 cell
 .proliferation. Cell number was determined by MTT a or
w3 x  .H thymidine incorporation b . There was a significant inhibi-
tion of BPB on proliferation of L929 and Swiss 3T3 cell lines
) )) .P -0.05, P -0.02 . Values represent the mean"S.E.M.
for 3 separate experiments, each in triplicate.
Fig. 11. The effect of AA on fibroblast proliferation. Fibroblast
 .  .L929 a or Swiss 3T3 b cell number was determined by MTT
in the presence or absence of AA on various concentrations. The
significance of the effect of AA on fibroblast proliferation at day
4 was: a, ) P -0.05; b, ) P -0.05. The results are the mean"
S.E.M. from 3 to 4 experiments, each in triplicate.
4.0% of the control. Similar results were obtained by
 .thymidine incorporation Fig. 10b . 1 mM BPB was
not toxic to fibroblasts when assayed by trypan blue
exclusion.
Addition of free AA to HL-60 cells in a range of
0.1–80 mM, did not affect their proliferation rate and
 .higher concentrations of AA 100–140 mM were
toxic to the cells. In the presence of 100 mM AA, the
percentage of dead cells was 12.5% after two days
and 45% after four days, while in the presence of 140
mM AA the percentage of dead cells was 50% after
two days and 90% after four days. The effect of free
AA on proliferation was also studied in fibroblast cell
lines. Addition of free AA in a range of 10–60 mM
to fibroblast L929 or Swiss S3T3 cell lines caused a
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significant increasing biphasic effect on cell prolifera-
tion with maximum effect at 40 mM AA, observed
 .only at day four Fig. 11 .
The effect of addition of the various PLA in-2
hibitors on HL-60 cell differentiation was studied.
 .  .BPB 0.1–0.75 mM , AACOCF 10 mM–30 mM3
 .or scalaradial 2.5 mM–7.5 mM did not induce
differentiation either alone or in combination with
 .optimal or suboptimal concentrations of 1,25 OH D2 3
 .or RA data not shown . Addition of free AA in a
range of 0.1–140 mM did not induce differentiation
in HL-60 cells.
4. Discussion
The present study shows that PLA activity and2
the release of AA are essential for the proliferation
process. Agents which inhibit proliferation of HL-60
 .cells, such as 1,25 OH D or RA, caused inhibition2 3
of PLA activity as measured by the release of AA2
stimulated by PMA. In accordance with these results,
the potent inhibitor of PLA activity, BPB, which2
covalently modify a histidine residue at the active site
w xof PLA 22,23 , inhibited both the proliferation of2
HL-60 cells and AA release induced by PMA in a
dose- and time-dependent manner. The specificity of
BPB to PLA is demonstrated in our recent study2
w x18 showing that in the presence of BPB PLA 2
activity is inhibited while the phosphorylation of
proteins induced by PKC activity is not affected.
Similarly, two other PLA inhibitors, the analog of2
w xAA, AACOCF 24 and the potent irreversible inac-3
w xtivator of PLA , scalaradial 25 , inhibited HL-602
cell proliferation in a dose- and time- dependent
manner. These results suggest that PLA activity2
plays an important role in regulating the proliferation
process in HL-60 cells. The inhibitory effect of BPB
on cell proliferation could be reversed by the addition
 .of free AA in a dose dependent manner Fig. 5 . This
effect was specific to AA and not to other fatty acids
such OA, or LA, indicating the importance of AA
metabolite for HL-60 proliferation. The three PLA 2
inhibitors used in our study did not change the cell
cycle distribution, but they caused a significant in-
crease in the doubling time of HL-60 cells. Their
 .effect is in contrast to that of 1,25 OH D or RA2 3
which inhibit proliferation of HL-60 by arresting the
 w x.cell cycle in G phase Table 1 and 26 . This1
discrepancy may be attributed to the fact that
 .1,25 OH D or RA inhibit proliferation and induce2 3
differentiation, while the PLA inhibitors only inhibit2
proliferation and do not induce differentiation.
The type of PLA that catalyzes the release of AA2
during proliferation and is inhibited by the different
PLA inhibitors used in our study is not yet known.2
Over the past decade a number of distinct types of
PLA have been isolated and characterized. The best2
known of these are a family of 14-kDa calcium
 . w xdependent secreted enzymes sPLA 21 , an 85-kDa2
 . w xcytosolic calcium dependent enzyme cPLA 202
w xand an intracellular calcium independent enzyme 27 .
In the present study we used both scalaradial, which
w xis known to be more specific to sPLA 21 , and2
AACOCF which is known to be more specific to3
w xcPLA 25 . Both inhibitors inhibited HL-60 cell2
proliferation to about 40% after 3 days, similar to the
effect of BPB. These results suggest that both sPLA 2
and cPLA participate in the proliferation process.2
These two types of PLA are present in HL-60 cells2
 .as shown by the presence of mRNA Fig. 6 and by
w xthe presence of the cPLA protein 28 . However,2
there is a limitation to using inhibitors, since although
the different inhibitors are more specific to certain
types of PLA they may inhibit other types as well2
w x25,29,30 . Other experiments are being conducted in
our laboratory to define the exact type of PLA that2
plays a role in the proliferation process.
The role of PLA was further emphasized in other2
cell lines. Inhibition of PLA activity by BPB sup-2
 .pressed fibroblast cell line proliferation Fig. 10 ,
indicating that this phenomena is not restricted to
HL-60 cells only, but may have more general impli-
cations. The importance of PLA activity for the2
proliferation process shown in our study is supported
by other investigations. The PLA inhibitors, BPB,2
quinacrine and 7,7-dimethyleicosadienoic, have been
shown to significantly inhibit colony formation of
erythroid progenitor cells in the presence or absence
 .of erythropoietin Epo which controls the prolifera-
tion and differentiation of erythroid progenitor cells
w x w x31 . In another study 32 when quiescent cells were
incubated with PLA type I for 24 h, DNA synthesis2
of fibroblast Swiss 3T3 cells was stimulated in a
dose-dependent manner. Furthermore, the exogenous
addition of PLA type II to fibroblast Swiss 3T3 and2
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BALBr3T3 cell lines was found to stimulate DNA
w xsynthesis 33 .
Addition of exogenous free AA did not affect the
proliferation rate of HL-60 cells. Similar to our re-
w xsults it has been reported 34 that addition of free
AA to U937 did not affect the rate of proliferation.
w xAnother study 35 has shown that 10 mM AA could
decrease growth of HL-60 cells by 50% as early as
18 h, but this growth inhibition was transient, and
cells were able to recover and grow to control levels
72 h following AA treatment. In contrast, a recent
w xstudy 36 reported the inhibitory effect of AA on
HL-60 cell proliferation, but only with concentrations
above )30 mM. In this study BSA alone, which
was used to present AA to the cells, inhibited cell
growth by 30%. At higher concentrations of AA 120
.mM , the inhibition of proliferation was due to apop-
tosis and necrosis, in accordance with the toxic effect
of high concentrations of AA on HL-60 cells shown
in our study. In contrast to HL-60 cells, addition of
free AA increased fibroblast cell growth, but the
effect was significant only after 96 h, suggesting
differences in sensitivity to AA in various cell lines.
It is possible that HL-60 cells proliferate at an opti-
mal rate so that addition of AA would be inefficient
in increasing the extent of proliferation. In accor-
dance with our results, two other studies have shown
that AA does not dramatically affect Swiss 3T3
fibroblast proliferation during the first few days. The
w xfirst study 37 showed that addition of free AA
caused a weak and non significant stimulatory effect
on proliferation in a dose-dependent manner within
w x24 h. The second one 38 reported that there was no
effect of AA on cell proliferation 40 h after addition
w xof AA. In another cell line, rat messangial cells 39 ,
exogenous AA caused increased proliferation.
The effect of the addition of free AA on differenti-
ation of HL-60 cells was studied. As anticipated by
the effect of the PLA inhibitors on proliferation, the2
addition of AA to HL-60 cells did not induce differ-
entiation.
In contrast to the significant effect of the three
PLA inhibitors on the proliferation of HL-60 cells,2
they did not affect the differentiation process, either
 .alone or together with 1,25 OH D or RA. Although2 3
the differentiation process is usually accompanied by
inhibition of proliferation, we demonstrate in the
present study that inhibition of PLA activity sup-2
pressed the proliferation process but did not induce
differentiation. These observations suggest that the
two processes may be differentially regulated in HL-
60 cells.
In conclusion, our study suggests that PLA activ-2
ity plays an important role in HL-60 and fibroblast
L929 and Swiss 3T3 cell proliferation. While the
inhibition of PLA suppresses proliferation, it is not2
sufficient to induce differentiation of HL-60 cells.
The type of PLA participating in the proliferation2
process has to be determined and is presently being
investigated.
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